| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |